Dauphine, Christine
Moazzez, Ashkan
Neal, Jasmin C.
Chlebowski, Rowan T.
Ozao-Choy, Junko
Article History
Received: 15 May 2020
Accepted: 27 June 2020
First Online: 28 July 2020
Disclosure
: Rowan T. Chlebowski is a consultant for Novartis, AstraZeneca, Genentech, Merck, Immunomedics, and Puma and received honorarium from Novartis and AstraZeneca.
: The authors have no conflicts of interest to declare.